drugset / Trial / NCT06642428

Effect of Vitamin D Supplementation on the Efficacy and Adverse Effects of Neoadjuvant Therapy in Patients with Breast Cancer

NCT06642428

Recruiting 140 enrolled Jiuda Zhao
RandomizedParallel-groupOpen-labelTreatment

Summary

This randomized controlled Phase III trial was designed to evaluate the impact of supplemental vitamin D (VD) on the efficacy and side effects of neoadjuvant therapy in patients with breast cancer.

Timeline

Start
2024-10-18
Primary completion
2026-01-31
Completion
2026-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ergocalciferol Small molecule 10 mg Other